Paydirt
TC
Insider

Timothy Coughlin

Director

Timothy Coughlin (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $631K of TVTX (18,000 sh × $35.03, as filed), executed Oct 31 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Jun 12
Filed Jun 16

Median ADV $123.0M across their filed names

Open performance
Volume by month
$631K$315K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2025 · sells $631KMay 2026 · sells $141KJun 2026 · sells $501K
Buys $0 Sells $1.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
TVTX Travere Therapeutics, Inc. TVTX · 0 buys · 3 sells 3 filings
Recent filings
TVTXSALE Travere Therapeutics, Inc. View filing → $501K
10,000 sh × $50.07
Exec Jun 12
Filed Jun 16 · 5:30 PM ET
TVTXSALE Travere Therapeutics, Inc. View filing → $141K
3,250 sh × $43.49
Exec May 15
Filed May 19 · 5:30 PM ET
TVTXSALE Travere Therapeutics, Inc. View filing → $631K
18,000 sh × $35.03
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET